Abstract
The search for new drug candidates in databases is of paramount importance in pharmaceutical chemistry. The selection of molecular subsets is greatly optimized and much more promising when potential drug-like molecules are detected a priori. In this work, about one hundred thousand molecules are ranked following a new methodology: a drug/non-drug classifier constructed by a consensual set of classification trees. The classification trees arise from the stochastic generation of training sets, which in turn are used to estimate probability factors of test molecules to be drug-like compounds. Molecules were represented by Topological Quantum Similarity Indices and their Graph Theoretical counterparts. The contribution of the present paper consists of presenting an effective ranking method able to improve the probability of finding drug-like substances by using these types of molecular descriptors.
Keywords: Drug-like molecules, Recursive partition trees, Topological quantum similarity indices, Topological indices, Consensus model.
Current Pharmaceutical Design
Title:Discriminating Drug-Like Compounds by Partition Trees with Quantum Similarity Indices and Graph Invariants
Volume: 22 Issue: 34
Author(s): Jesus V. de Julián-Ortiz, Rafael Gozalbes and Emili Besalú
Affiliation:
Keywords: Drug-like molecules, Recursive partition trees, Topological quantum similarity indices, Topological indices, Consensus model.
Abstract: The search for new drug candidates in databases is of paramount importance in pharmaceutical chemistry. The selection of molecular subsets is greatly optimized and much more promising when potential drug-like molecules are detected a priori. In this work, about one hundred thousand molecules are ranked following a new methodology: a drug/non-drug classifier constructed by a consensual set of classification trees. The classification trees arise from the stochastic generation of training sets, which in turn are used to estimate probability factors of test molecules to be drug-like compounds. Molecules were represented by Topological Quantum Similarity Indices and their Graph Theoretical counterparts. The contribution of the present paper consists of presenting an effective ranking method able to improve the probability of finding drug-like substances by using these types of molecular descriptors.
Export Options
About this article
Cite this article as:
Julián-Ortiz V. de Jesus, Gozalbes Rafael and Besalú Emili, Discriminating Drug-Like Compounds by Partition Trees with Quantum Similarity Indices and Graph Invariants, Current Pharmaceutical Design 2016; 22 (34) . https://dx.doi.org/10.2174/1381612822666160601100218
DOI https://dx.doi.org/10.2174/1381612822666160601100218 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Physiological and Non-Redundant Functions of PKC Isotypes in T Lymphocytes
Current Immunology Reviews (Discontinued) Current Neuropharmacology Volume 9, Supplement 1, September 2011
Current Neuropharmacology Impacts and Concerns for vCJD in Blood Transfusion: Current Status
Current Molecular Medicine Tissue-Specific Methylation of Long Interspersed Nucleotide Element-1 of Homo Sapiens (L1Hs) During Human Embryogenesis and Roles in Neural Tube Defects
Current Molecular Medicine Implications of Epigenetic Mechanisms and their Targets in Cerebral Ischemia Models
Current Neuropharmacology Roles and Biomedical Applications of Haemolymph Lectin
Current Pharmaceutical Biotechnology Potential Applications of Hydrogen Sulfide-Induced Suspended Animation
Current Medicinal Chemistry Understanding the Use of Immunosuppressive Agents in the Clinical Management of IBD
Current Drug Targets Biology of Cox-2: An Application in Cancer Therapeutics
Current Drug Targets Mechanisms of Neuroprotection by Polyphenols
Current Medicinal Chemistry - Central Nervous System Agents Relevance of an Academic GMP Pan-European Vector Infra-Structure (PEVI)
Current Gene Therapy Do Human Lipoxygenases have a PDZ Regulatory Domain?
Current Molecular Medicine Recent Advances in the Treatment of Amyotrophic Lateral Sclerosis. Emphasis on Kynurenine Pathway Inhibitors
Central Nervous System Agents in Medicinal Chemistry Therapeutic Approaches for Dominant Muscle Diseases: Highlight on Myotonic Dystrophy
Current Gene Therapy Solution-Phase Parallel Synthesis of N,6-Disubstituted Isoquinuclidines as Ibogaine Analogs
Letters in Drug Design & Discovery Potential Application of Network Descriptions for Understanding Conformational Changes and Protonation States of ABC Transporters
Current Pharmaceutical Design 5-HT7 Receptors
Current Drug Targets - CNS & Neurological Disorders MAP Kinase Pathways in Neuronal Cell Death
CNS & Neurological Disorders - Drug Targets Cordycepin Exerts Neuroprotective Effects via an Anti-Apoptotic Mechanism based on the Mitochondrial Pathway in a Rotenone-Induced Parkinsonism Rat Model
CNS & Neurological Disorders - Drug Targets Mathematical Nanotoxicoproteomics: Quantitative Characterization of Effects of Multi-walled Carbon Nanotubes (MWCNT) and TiO2 Nanobelts (TiO2-NB) on Protein Expression Patterns in Human Intestinal Cells
Current Computer-Aided Drug Design